Statistics
Total Visits
| Views | |
|---|---|
| Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin +/- amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial | 154 |
Total Visits per Month
| November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | |
|---|---|---|---|---|---|---|---|
| Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin +/- amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial | 3 | 6 | 2 | 13 | 24 | 7 | 0 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 97 |
| Germany | 9 |
| Brazil | 7 |
| China | 7 |
| Australia | 6 |
| Russia | 5 |
| Czechia | 4 |
| Argentina | 3 |
| Belgium | 2 |
| United Kingdom | 2 |
Top City Views
| Views | |
|---|---|
| Ashburn | 16 |
| Austin | 14 |
| San Mateo | 10 |
| Fairfield | 9 |
| San Diego | 6 |
| Ann Arbor | 4 |
| Des Moines | 4 |
| Dearborn | 3 |
| Portland | 3 |
| Sacramento | 2 |